Literature DB >> 23207922

Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care.

José Mario López-Saca1, José Maria López-Picazo, Ana Larumbe, Juli Urdíroz, Carlos Centeno.   

Abstract

Within an oncology setting, certain chemotherapy drugs, such as cisplatin, may lead to magnesium loss causing nephropathy. Neurological and cardiovascular symptoms caused by hypomagnesaemia are well known. The relationship between serious hypomagnesemia and severe pain is not well documented but nevertheless, when faced with unexplained episodes of pain which do not respond to powerful analgesics, it is important to review blood magnesium levels. We present two cases of opioid-refractory pain attacks. Patients received drugs which have been linked to hypomagnesemia. In both cases, endovenous magnesium replacement led to a drastic improvement in pain management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207922     DOI: 10.1007/s00520-012-1669-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

1.  [Seizures secondary to hypomagnesemia in patients with short bowel syndrome].

Authors:  Maria G Guijarro de Armas; B Vega Piñero; S J Rodríguez Álvarez; S Civantos Modino; J M Montaño Martínez; I Pavón de Paz; S Monereo Megías
Journal:  Nutr Hosp       Date:  2010 Nov-Dec       Impact factor: 1.057

Review 2.  Coadjuvant analgesics for cancer pain: using the clinical queries PubMed tool.

Authors:  Luis Enrique Chaparro Gómez; José Andrés Calvache España; Lina Marcela Arbeláez León
Journal:  Cir Cir       Date:  2010 Mar-Apr       Impact factor: 0.361

Review 3.  Cisplatin and hypomagnesemia.

Authors:  H Lajer; G Daugaard
Journal:  Cancer Treat Rev       Date:  1999-02       Impact factor: 12.111

4.  [Visual hallucinations and unusual pain related to hypomagnesemia in an advanced cancer patient].

Authors:  Joaquim Bosch-Barrera; Julia Urdiroz; Carlos Centeno
Journal:  An Sist Sanit Navar       Date:  2010 Sep-Dec       Impact factor: 0.829

5.  Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals.

Authors:  H F Schimatschek; R Rempis
Journal:  Magnes Res       Date:  2001-12       Impact factor: 1.115

6.  Meta-analysis of incidence and risk of hypomagnesemia with cetuximab for advanced cancer.

Authors:  Yunfei Cao; Cun Liao; Aihua Tan; Lidan Liu; Feng Gao
Journal:  Chemotherapy       Date:  2010-11-18       Impact factor: 2.544

7.  Hypomagnesemia is a frequent finding in the emergency department in patients with chest pain.

Authors:  M Salem; N Kasinski; A M Andrei; T Brussel; M R Gold; A Conn; B Chernow
Journal:  Arch Intern Med       Date:  1991-11

8.  Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.

Authors:  Magdalena Bujalska; Ewelina Malinowska; Helena Makulska-Nowak; Stanisław Witold Gumułka
Journal:  Pharmacology       Date:  2008-08-14       Impact factor: 2.547

Review 9.  Hypomagnesaemia due to use of proton pump inhibitors--a review.

Authors:  M T Kuipers; H D Thang; A B Arntzenius
Journal:  Neth J Med       Date:  2009-05       Impact factor: 1.422

10.  Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia.

Authors:  R Whang; T O Oei; J K Aikawa; A Watanabe; J Vannatta; A Fryer; M Markanich
Journal:  Arch Intern Med       Date:  1984-09
View more
  3 in total

1.  Expression of magnesium transporter genes in head and neck cancer patients underwent neoadjuvant cisplatin-based chemotherapy.

Authors:  Yu-Jung Lin; Fu-Chou Cheng; Li-Sheng Chien; Jin-Ching Lin; Rong-San Jiang; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-01       Impact factor: 2.503

Review 2.  Delirium in patients with cancer: assessment, impact, mechanisms and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Nat Rev Clin Oncol       Date:  2014-09-02       Impact factor: 66.675

3.  Doxorubicin Loaded Magnesium Oxide Nanoflakes as pH Dependent Carriers for Simultaneous Treatment of Cancer and Hypomagnesemia.

Authors:  Tharindu A Ranathunge; D G G P Karunaratne; R M G Rajapakse; Davita L Watkins
Journal:  Nanomaterials (Basel)       Date:  2019-02-06       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.